Decentralized clinical trials (DCTs) utilizing direct-to-patient (DTP) services, including the provision of drug products, ancillary supplies, and home healthcare visits, have demonstrated significant benefits in patient recruitment and enrollment and reducing burdens on patients and have facilitated trials investigating rare diseases with geographically dispersed populations and other challenges that were previously impossible.